Gemida, Jocelyn A.

HRN: 25-18-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2024
06/19/2024
IV
2.25grams
Q8H
Rectal Adenocarcinoma Stage 4
Waiting Final Action 
06/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/12/2024
06/24/2024
IV
500mg
Q8H
Rectal Adenocarcinoma Stage 4
Waiting Final Action 
06/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/14/2024
06/26/2024
IV
4.5g
Q6h
Rectal Adenocarcinoma Stage 4
Waiting Final Action 
06/15/2024
FLUCONAZOLE 150MG (CAP)
06/15/2024
06/21/2024
ORAL
150mg
OD
T/C Oral Candiasis
Waiting Final Action 
06/23/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/23/2024
06/30/2024
TOPICAL
Apply Thinly
Every 12hours
Burn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: